Patent Yard Sign in
Expired Australian patentAustralia

Synergising association having an antagonist effect on NK1 and NK2 receptors

AU 1994058627 · Applicant: Aventis Pharma Sa

AusPat record

Overview

Drawings and full text

Its specification, documents and status are on IP Australia's AusPat.

Open the AusPat record

Read the whole patent

Listed from its IP Australia record in Patent Yard's archive of Australian patents past their term. Its claims, description and drawings are in the AusPat record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed January 18, 1994 and granted January 15, 1998. An Australian standard patent lasts 20 years from its date of patent, which is at most a year after this filing, so its term ended by January 18, 2015.
  • A pharmaceutical extension adds at most five years, so even that would have ended by January 18, 2020.
  • We check Australian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledJanuary 18, 1994
GrantedJanuary 15, 1998
Term ended byJanuary 18, 2015
Application numberAU 1994058627
Classification (IPC)A61K31/445 +2 more

Timeline

Timeline From IP Australia dates

1995199820012004200720102013Application filedJan 18, 1994Patent grantedJan 15, 1998Term ended byJan 18, 2015

Sources & verification

Everything on this page comes from the IP Australia record linked above. Data from IP Australia's IPGOD, licensed under CC BY 2.5 AU.